Hepatitis B Immunoglobulin P pre-filled syringes
Ingredients in every ml
|Human Protein||100 - 170 mg|
|Immunoglobulin at least||95 %|
|Antibodies to Hbs antigen at least||200 IU|
Each package contains
|ATC Level 1:||J - Antiinfectives for systemic use|
|ATC Level 2:||J06 - Immune Sera and Immunoglobulins|
|ATC Level 3:||J06B - Immunoglobulins|
0 YEARS OLD AND ABOVE
– Prevention of hepatitis B in case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown): 12 IU/kg body weight, at least 500 IU, depending in the intensity of exposure, as soon as possible after exposure, and preferably within 72 hours.
– Immunoprophylaxis of hepatitis B in haemodialysed patients: 8 to 12 IU/kg body weight (maximal 500 IU), every 2 months until seroconversion following vaccination.
– Prevention of hepatitis B in the newborn, of hepatitis B virus carrier-mother, at birth or as soon as possible after birth: 30 to 100 IU/kg body weight (normally 1 ml). The hepatitis B immunoglobulin administration may need to be repeated until seroconversion following vaccination.
In all these situations, vaccination against hepatitis B virus is highly recommended. The first vaccine dose can be injected the same day as human hepatitis B immunoglobulin, however in different sites.
In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination, and for whom continuous prevention is necessary, administration of 500 IU to Adults and 8 IU/kg body weight to children every 2 months can be considered; a minimum protective antibody titre is considered to be 10 mIU/ml.
Immunoprophylaxis of hepatitis B
– In case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown)
– In haemodialysed patients, until vaccination has become effective.
– In the newborn of a hepatitis B virus carrier-mother
– In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.
National and/or WHO guidelines regarding protection against hepatitis B infection should be observed.
All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.